This podcast discusses monoclonal antibodies as cancer therapies, how they work, and their advantages compared with other cancer treatments.
In this podcast learn about therapeutic drug monitoring and why we need to monitor drug levels for some patients.
Could cross-adsorbed secondary antibodies reduce your background and improve your results? Learn about cross-adsorption and how it removes undesirable cross-reactivity in this podcast.
Do you know where on the primary antibody your secondary antibody binds? Learn why it can impact your results and how to choose an appropriate secondary antibody.
This podcast from Bio-Rad highlights five important things to consider when you are selecting secondary antibodies for multiplexing experiments.
This podcast covers the main factors that impact which secondary antibodies you should use in your experiments for the best results.
Have you noticed that therapeutic antibodies have complex and often unpronounceable names? It probably won’t surprise you to hear that there is a logic behind these names which convey information about the type of drug and its mechanism of action. In this podcast, we explain what International Non-proprietary Names are, and the logic behind their use.
Do you know the frequency of your population of interest? Learn about the impact of cell frequency on flow cytometry experiments and how you can optimize your conditions to improve detection of rare populations in this podcast from Bio-Rad.
Bio-Rad antibody expert, Michael Schwenkert, talks about the challenges for bioanalysis of CAR-T cells and how they can be addressed by the design and generation of customized anti-idiotypic antibodies.
In this podcast, learn how to prepare blood samples ready for flow cytometry experiments with Bio-Rad’s top three tips.